Continuing PSA screening in older men is common practice but not recommended, highlighting the need for clearer guidance.

Savolitinib plus osimertinib may be a chemotherapy-free treatment option for patients with EGFR-mutant, advanced NSCLC with MET overexpression/amplification whose disease has progressed on osimertinib ...

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient (dMMR), surgically resectable endometrial cancer, according to findings presented at the SGO 2025 Annual ...

Black and American Indian patients are less likely to have elevated CA-125 levels compared with White patients.

Approximately one-third of all patients with ALL had at least one major comorbidity, and 4% had 4 or more comorbidities.

Distinct differences exist in the supportive care needs and the factors that influence those needs between male and female patients with colorectal cancer.

Inflammatory bowel disease (IBD) is associated with increased risks for genitourinary cancers, including prostate cancer and renal cell carcinoma (RCC), according to study results presented at the ...

Researchers evaluated billing for early palliative care among Medicare beneficiaries who were newly diagnosed with 1 of 6 common distant-stage cancers.

Researchers sought to determine the local recurrence and overall survival with breast conserving therapy in cases of multifocal or multicentric breast cancer.

Adding afuresertib to paclitaxel did not improve outcomes in patients with platinum-resistant ovarian cancer in a phase 2 trial.

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.

The real-world safety profile of tisagenlecleucel appears to be more favourable than that reported in the JULIET study, which led to its FDA approval.